vs
DUCOMMUN INC（DCO）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
DUCOMMUN INC的季度营收约是REPLIGEN CORP的1.1倍（$215.8M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 3.4%，领先3.3%），REPLIGEN CORP同比增速更快（13.6% vs 9.4%），REPLIGEN CORP自由现金流更多（$17.6M vs $-78.8M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 6.3%）
杜科蒙是一家全球性航空航天与国防制造企业，主要供应复杂结构部件、电子系统，提供专业工程服务，覆盖商用航空、军事国防、航天领域客户，交付适用于关键航空航天场景的高可靠性解决方案。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
DCO vs RGEN — 直观对比
营收规模更大
DCO
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出4.3%
9.4%
净利率更高
RGEN
高出3.3%
3.4%
自由现金流更多
RGEN
多$96.3M
$-78.8M
两年增速更快
RGEN
近两年复合增速
6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $215.8M | $197.9M |
| 净利润 | $7.4M | $13.3M |
| 毛利率 | 27.7% | 52.5% |
| 营业利润率 | 6.5% | 9.0% |
| 净利率 | 3.4% | 6.7% |
| 营收同比 | 9.4% | 13.6% |
| 净利润同比 | 9.9% | 143.9% |
| 每股收益（稀释后） | $0.52 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DCORGEN
| Q4 25 | $215.8M | $197.9M | ||
| Q3 25 | $212.6M | $188.8M | ||
| Q2 25 | $202.3M | $182.4M | ||
| Q1 25 | $194.1M | $169.2M | ||
| Q4 24 | $197.3M | $174.1M | ||
| Q3 24 | $201.4M | $154.9M | ||
| Q2 24 | $197.0M | $154.1M | ||
| Q1 24 | $190.8M | $151.3M |
净利润DCORGEN
| Q4 25 | $7.4M | $13.3M | ||
| Q3 25 | $-64.4M | $14.9M | ||
| Q2 25 | $12.6M | $14.9M | ||
| Q1 25 | $10.5M | $5.8M | ||
| Q4 24 | $6.8M | $-30.3M | ||
| Q3 24 | $10.1M | $-654.0K | ||
| Q2 24 | $7.7M | $3.3M | ||
| Q1 24 | $6.8M | $2.1M |
毛利率DCORGEN
| Q4 25 | 27.7% | 52.5% | ||
| Q3 25 | 26.6% | 53.2% | ||
| Q2 25 | 26.6% | 50.0% | ||
| Q1 25 | 26.6% | 53.6% | ||
| Q4 24 | 23.5% | 26.1% | ||
| Q3 24 | 26.2% | 50.0% | ||
| Q2 24 | 26.0% | 49.8% | ||
| Q1 24 | 24.6% | 49.5% |
营业利润率DCORGEN
| Q4 25 | 6.5% | 9.0% | ||
| Q3 25 | -37.7% | 8.9% | ||
| Q2 25 | 8.5% | 7.6% | ||
| Q1 25 | 8.5% | 3.9% | ||
| Q4 24 | 5.3% | -17.7% | ||
| Q3 24 | 7.6% | -5.1% | ||
| Q2 24 | 7.1% | 1.0% | ||
| Q1 24 | 6.6% | 1.3% |
净利率DCORGEN
| Q4 25 | 3.4% | 6.7% | ||
| Q3 25 | -30.3% | 7.9% | ||
| Q2 25 | 6.2% | 8.2% | ||
| Q1 25 | 5.4% | 3.4% | ||
| Q4 24 | 3.4% | -17.4% | ||
| Q3 24 | 5.0% | -0.4% | ||
| Q2 24 | 3.9% | 2.2% | ||
| Q1 24 | 3.6% | 1.4% |
每股收益（稀释后）DCORGEN
| Q4 25 | $0.52 | $0.24 | ||
| Q3 25 | $-4.30 | $0.26 | ||
| Q2 25 | $0.82 | $0.26 | ||
| Q1 25 | $0.69 | $0.10 | ||
| Q4 24 | $0.45 | $-0.55 | ||
| Q3 24 | $0.67 | $-0.01 | ||
| Q2 24 | $0.52 | $0.06 | ||
| Q1 24 | $0.46 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $45.3M | $767.6M |
| 总债务越低越好 | $298.8M | $542.2M |
| 股东权益账面价值 | $662.1M | $2.1B |
| 总资产 | $1.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.45× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资DCORGEN
| Q4 25 | $45.3M | $767.6M | ||
| Q3 25 | $50.9M | $748.7M | ||
| Q2 25 | $37.1M | $708.9M | ||
| Q1 25 | $30.7M | $697.2M | ||
| Q4 24 | $37.1M | $757.4M | ||
| Q3 24 | $37.3M | $784.0M | ||
| Q2 24 | $29.4M | $809.1M | ||
| Q1 24 | $32.1M | $780.6M |
总债务DCORGEN
| Q4 25 | $298.8M | $542.2M | ||
| Q3 25 | $215.0M | $537.9M | ||
| Q2 25 | $218.1M | — | ||
| Q1 25 | $229.9M | — | ||
| Q4 24 | $229.8M | $525.6M | ||
| Q3 24 | $246.0M | — | ||
| Q2 24 | $250.9M | — | ||
| Q1 24 | $253.9M | — |
股东权益DCORGEN
| Q4 25 | $662.1M | $2.1B | ||
| Q3 25 | $649.0M | $2.1B | ||
| Q2 25 | $707.8M | $2.1B | ||
| Q1 25 | $693.0M | $2.0B | ||
| Q4 24 | $682.5M | $2.0B | ||
| Q3 24 | $665.6M | $2.0B | ||
| Q2 24 | $655.9M | $2.0B | ||
| Q1 24 | $645.5M | $2.0B |
总资产DCORGEN
| Q4 25 | $1.2B | $2.9B | ||
| Q3 25 | $1.2B | $2.9B | ||
| Q2 25 | $1.1B | $2.9B | ||
| Q1 25 | $1.1B | $2.9B | ||
| Q4 24 | $1.1B | $2.8B | ||
| Q3 24 | $1.1B | $2.8B | ||
| Q2 24 | $1.1B | $2.9B | ||
| Q1 24 | $1.1B | $2.8B |
负债/权益比DCORGEN
| Q4 25 | 0.45× | 0.26× | ||
| Q3 25 | 0.33× | 0.26× | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.33× | — | ||
| Q4 24 | 0.34× | 0.27× | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.39× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-74.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-78.8M | $17.6M |
| 自由现金流率自由现金流/营收 | -36.5% | 8.9% |
| 资本支出强度资本支出/营收 | 1.9% | 4.1% |
| 现金转化率经营现金流/净利润 | -10.03× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-48.6M | $93.9M |
8季度趋势，按日历期对齐
经营现金流DCORGEN
| Q4 25 | $-74.7M | $25.7M | ||
| Q3 25 | $18.1M | $48.1M | ||
| Q2 25 | $22.4M | $28.6M | ||
| Q1 25 | $771.0K | $15.0M | ||
| Q4 24 | $18.4M | $39.2M | ||
| Q3 24 | $13.9M | $49.3M | ||
| Q2 24 | $3.5M | $42.2M | ||
| Q1 24 | $-1.6M | $44.7M |
自由现金流DCORGEN
| Q4 25 | $-78.8M | $17.6M | ||
| Q3 25 | $16.0M | $43.4M | ||
| Q2 25 | $18.1M | $21.5M | ||
| Q1 25 | $-4.0M | $11.4M | ||
| Q4 24 | $14.6M | $33.6M | ||
| Q3 24 | $12.0M | $42.3M | ||
| Q2 24 | $144.0K | $37.4M | ||
| Q1 24 | $-6.6M | $36.4M |
自由现金流率DCORGEN
| Q4 25 | -36.5% | 8.9% | ||
| Q3 25 | 7.5% | 23.0% | ||
| Q2 25 | 9.0% | 11.8% | ||
| Q1 25 | -2.1% | 6.8% | ||
| Q4 24 | 7.4% | 19.3% | ||
| Q3 24 | 5.9% | 27.3% | ||
| Q2 24 | 0.1% | 24.3% | ||
| Q1 24 | -3.5% | 24.0% |
资本支出强度DCORGEN
| Q4 25 | 1.9% | 4.1% | ||
| Q3 25 | 1.0% | 2.5% | ||
| Q2 25 | 2.1% | 3.9% | ||
| Q1 25 | 2.5% | 2.1% | ||
| Q4 24 | 2.0% | 3.2% | ||
| Q3 24 | 1.0% | 4.5% | ||
| Q2 24 | 1.7% | 3.1% | ||
| Q1 24 | 2.6% | 5.5% |
现金转化率DCORGEN
| Q4 25 | -10.03× | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | 1.79× | 1.92× | ||
| Q1 25 | 0.07× | 2.57× | ||
| Q4 24 | 2.72× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 0.45× | 12.70× | ||
| Q1 24 | -0.24× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DCO
| Other | $90.1M | 42% |
| Militaryand Space | $60.0M | 28% |
| Electronic Systems Segment | $31.3M | 15% |
| Commercial Aerospace | $24.8M | 11% |
| Estimate At Completion Adjustment | $6.6M | 3% |
| Industrial | $3.0M | 1% |
RGEN
暂无分部数据
